Latest Articles

Publication Date
Did you know one of the advantages of IVF treatment is its ability to address many different causes of infertility? IVF can help overcome challenges such as tubal blockage, ovulation issues, problems with sperm and egg interaction, poor sperm quality or quantit - Facebook

Did you know one of the advantages of IVF treatment is its ability to address many different causes of infertility? IVF can help overcome challenges such as tubal blockage, ovulation …

Published: Feb. 25, 2026, 3 p.m.
Flament to miss game for wife's fertility treatment - AOL.com

Flament to miss game for wife's fertility treatment AOL.com

Published: Feb. 20, 2026, 12:29 a.m.
Doctor addresses endometriosis myths and treatment options - WTOC

Doctor addresses endometriosis myths and treatment options WTOC

Published: Feb. 18, 2026, 5:38 p.m.
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Feb. 18, 2026, 3:18 p.m.
Taskmaster star Fatiha El-Ghorri opens up about cancer treatment - AOL.com

Taskmaster star Fatiha El-Ghorri opens up about cancer treatment AOL.com

Published: Feb. 17, 2026, 8:09 a.m.
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com

Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com

Published: Feb. 11, 2026, 12:24 p.m.
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram

AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram

Published: Feb. 11, 2026, 3:33 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India

Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE

Published: Feb. 10, 2026, 10:07 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!